Molecular imaging and therapy of atherosclerosis with targeted nanoparticles
暂无分享,去创建一个
S. Caruthers | P. Winter | A. Neubauer | S. Wickline | G. Lanza | Patrick M. Winter | Shelton D. Caruthers | Samuel A. Wickline | Gregory M. Lanza | Anne M. Neubauer
[1] Craig J. Hawker,et al. The Convergence of Synthetic Organic and Polymer Chemistries , 2005, Science.
[2] S. Schmitz,et al. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. , 2000, Investigative radiology.
[3] A. Haase,et al. Fast 19F-NMR imaging in vivo using FLASH-MRI. , 1994, Magnetic resonance imaging.
[4] Vasilis Ntziachristos,et al. In Vivo Imaging of Proteolytic Activity in Atherosclerosis , 2002, Circulation.
[5] J. Werkmeister,et al. MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[6] S. Gambhir,et al. Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.
[7] Samuel A Wickline,et al. Targeted contrast agents for magnetic resonance imaging and ultrasound. , 2005, Current opinion in biotechnology.
[8] Patrick Winter,et al. Applications of Nanotechnology to Atherosclerosis, Thrombosis, and Vascular Biology , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[9] Leon Hirsch,et al. Nanoshell-Enabled Photonics-Based Imaging and Therapy of Cancer , 2004, Technology in cancer research & treatment.
[10] Grace Hu,et al. Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles , 2005, Magnetic resonance in medicine.
[11] M. Ferrari,et al. Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group. , 2003, Circulation.
[12] J. G. Miller,et al. In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. , 1998, The Journal of the Acoustical Society of America.
[13] P. Shah,et al. Role of inflammation and metalloproteinases in plaque disruption and thrombosis , 1998, Vascular medicine.
[14] Shuming Nie,et al. Quantum dot-encoded beads. , 2005, Methods in molecular biology.
[15] S. Wickline,et al. Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model , 2002, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.
[16] Jeff W M Bulte,et al. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques , 2003, Transplantation.
[17] J. G. Miller,et al. In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[18] S. Mousa,et al. Alpha(v)beta(3) integrin in angiogenesis and restenosis. , 2001, Drug news & perspectives.
[19] D. P. O'Neal,et al. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. , 2004, Cancer letters.
[20] V. Fuster,et al. Lipid-Rich Atherosclerotic Plaques Detected by Gadofluorine-Enhanced In Vivo Magnetic Resonance Imaging , 2004, Circulation.
[21] Ralph Weissleder,et al. Transport Of Surface‐Modified Nanoparticles Through Cell Monolayers , 2005, Chembiochem : a European journal of chemical biology.
[22] Jamey P Weichert,et al. Imaging of murine liver tumor using microCT with a hepatocyte-selective contrast agent: accuracy is dependent on adequate contrast enhancement. , 2004, The Journal of surgical research.
[23] Harvey R Herschman,et al. Molecular Imaging: Looking at Problems, Seeing Solutions , 2003, Science.
[24] J. Pickard,et al. Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography , 2002, Circulation.
[25] L. Petit,et al. Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDL. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[26] D. McPherson,et al. In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. , 1999, Journal of the American College of Cardiology.
[27] S James Adelstein,et al. Molecular targeting with radionuclides: state of the science. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[28] E. Ritman,et al. Simvastatin Preserves the Structure of Coronary Adventitial Vasa Vasorum in Experimental Hypercholesterolemia Independent of Lipid Lowering , 2002, Circulation.
[29] R Weissleder,et al. Targeted contrast agents in MR imaging. , 1996, Magnetic resonance imaging clinics of North America.
[30] J. Debatin,et al. Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.
[31] S. Wickline,et al. Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs. , 1997, Circulation.
[32] René M. Botnar,et al. Molecular Magnetic Resonance Imaging of Atrial Clots in a Swine Model , 2005, Circulation.
[33] Ralph Weissleder,et al. Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.
[34] Eric T Ahrens,et al. In vivo imaging platform for tracking immunotherapeutic cells , 2005, Nature Biotechnology.
[35] Erkki Ruoslahti,et al. Nanocrystal targeting in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[36] S. Bachilo,et al. Near-infrared fluorescence microscopy of single-walled carbon nanotubes in phagocytic cells. , 2004, Journal of the American Chemical Society.
[37] Rika Takikawa,et al. [In-vivo visualization of gene expression using magnetic resonance imaging]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[38] S. Mousa,et al. Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit. , 2001, Circulation.
[39] Shelton D Caruthers,et al. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. , 2003, Cancer research.
[40] Ralph Weissleder,et al. Magnetic relaxation switches capable of sensing molecular interactions , 2002, Nature Biotechnology.
[41] René M. Botnar,et al. In Vivo Magnetic Resonance Imaging of Coronary Thrombosis Using a Fibrin-Binding Molecular Magnetic Resonance Contrast Agent , 2004, Circulation.
[42] P. Constantinides,et al. Plaque fissures in human coronary thrombosis , 1966 .
[43] Samuel A Wickline,et al. Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery. , 2005, Ultrasound in medicine & biology.
[44] Wadih Arap,et al. Design and validation of a bifunctional ligand display system for receptor targeting. , 2004, Chemistry & biology.
[45] Alexander Petrovsky,et al. Oligomerization of Paramagnetic Substrates Result in Signal Amplification and Can be Used for MR Imaging of Molecular Targets , 2002, Molecular imaging.
[46] J. Hamers,et al. [Methods and techniques]. , 1997, Verpleegkunde.
[47] Raymond C. Boston,et al. Dynamic Imaging of Allogeneic Mesenchymal Stem Cells Trafficking to Myocardial Infarction , 2005, Circulation.
[48] M. Bednarski,et al. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. , 1998, Nature medicine.
[49] Jeff W M Bulte,et al. Monitoring cell therapy using iron oxide MR contrast agents. , 2004, Current pharmaceutical biotechnology.
[50] S. Bachilo,et al. Versatile visualization of individual single-walled carbon nanotubes with near-infrared fluorescence microscopy. , 2005, Nano letters.
[51] T Suzuki,et al. Considerable Time From the Onset of Plaque Rupture and/or Thrombi Until the Onset of Acute Myocardial Infarction in Humans: Coronary Angiographic Findings Within 1 Week Before the Onset of Infarction , 2000, Circulation.
[52] Ergin Atalar,et al. In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction , 2003, Circulation.
[53] H. Harashima,et al. Optimization of antitumor effect of liposomally encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[54] Bruno Brochet,et al. Macrophage Imaging in Central Nervous System and in Carotid Atherosclerotic Plaque Using Ultrasmall Superparamagnetic Iron Oxide in Magnetic Resonance Imaging , 2004, Investigative radiology.
[55] Renu Virmani,et al. Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.
[56] M. Corjay,et al. αvβ3, αvβ5, and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formation , 1999 .
[57] S A Wickline,et al. Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques , 2001, Circulation.
[58] P R Bell,et al. Angiogenesis and the atherosclerotic carotid plaque: association between symptomatology and plaque morphology , 1999, Journal of vascular surgery.
[59] F. Blankenberg,et al. Noninvasive strategies to image cardiovascular apoptosis. , 2001, Cardiology clinics.
[60] M A Konerding,et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. , 1999, Circulation.
[61] Samuel A. Wickline,et al. Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles , 2003 .
[62] Martin J Graves,et al. In Vivo Detection of Macrophages in Human Carotid Atheroma: Temporal Dependence of Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced MRI , 2004, Stroke.
[63] R. Zhou,et al. MR and fluorescent imaging of low-density lipoprotein receptors. , 2004, Academic radiology.
[64] R. Virmani,et al. Sustained Reduction of In-Stent Neointimal Growth With the Use of a Novel Systemic Nanoparticle Paclitaxel , 2002, Circulation.
[65] George A. Mensah,et al. Sudden Cardiac Death in the United States, 1989 to 1998 , 2001, Circulation.
[66] S A Wickline,et al. Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles. , 2000, Magnetic resonance in medicine.
[67] A. Newby,et al. Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. , 1999, Cardiovascular research.
[68] J. G. Miller,et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. , 1996, Circulation.
[69] R E Jacobs,et al. A model for MRI contrast enhancement using T1 agents. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[70] Yixia Zhang,et al. Immunohistochemical study of intimal microvessels in coronary atherosclerosis. , 1993, The American journal of pathology.
[71] R. Stafford,et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[72] John M Pauly,et al. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles , 2005, Magnetic resonance in medicine.
[73] Shelton D Caruthers,et al. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI , 2004, Magnetic resonance in medicine.
[74] Lynn W. Jelinski,et al. Nuclear magnetic resonance spectroscopy. , 1990, Analytical chemistry.
[75] Susannah H Bloch,et al. Radiation-Force Assisted Targeting Facilitates Ultrasonic Molecular Imaging , 2004, Molecular imaging.
[76] R. Weissleder,et al. Molecular Imaging of Factor XIIIa Activity in Thrombosis Using a Novel, Near-Infrared Fluorescent Contrast Agent That Covalently Links to Thrombi , 2004, Circulation.
[77] Patrick J. Gaffney,et al. Quantitative “magnetic resonance immunohistochemistry” with ligand‐targeted 19F nanoparticles , 2004 .
[78] F. Sarkar,et al. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. , 1995, The Journal of clinical investigation.
[79] L W Jelinski,et al. Nuclear magnetic resonance spectroscopy. , 1995, Academic radiology.
[80] Jeff W M Bulte,et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. , 2003, Radiology.
[81] M. Strano,et al. Near-infrared optical sensors based on single-walled carbon nanotubes , 2004, Nature materials.
[82] J. Isner,et al. Cancer and atherosclerosis: the broad mandate of angiogenesis. , 1999, Circulation.
[83] Kerry K. Karukstis,et al. Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent: Implications for Rational Therapy of Restenosis , 2002, Circulation.
[84] M. E. Kooi,et al. Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging , 2003, Circulation.
[85] Shelton D Caruthers,et al. In Vitro Demonstration Using 19F Magnetic Resonance to Augment Molecular Imaging With Paramagnetic Perfluorocarbon Nanoparticles at 1.5 Tesla , 2006, Investigative radiology.
[86] Shelton D Caruthers,et al. Molecular imaging of human thrombus with computed tomography. , 2005, Academic radiology.
[87] Shelton D Caruthers,et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. , 2003, Circulation.
[88] Stasia A. Anderson,et al. Magnetic resonance contrast enhancement of neovasculature with αvβ3‐targeted nanoparticles , 2000 .
[89] Trevor Douglas,et al. Paramagnetic viral nanoparticles as potential high‐relaxivity magnetic resonance contrast agents , 2005, Magnetic resonance in medicine.
[90] J. Goldstein. Multifocal coronary plaque instability. , 2002, Progress in cardiovascular diseases.
[91] S. Simon,et al. AUGMENTED AND SELECTIVE DELIVERY OF LIQUID PERFLUOROCARBON NANOPARTICLES TO MELANOMA CELLS WITH NONCAVITATIONAL ULTRASOUND , 2003 .
[92] D. McPherson,et al. Left Ventricular Thrombus Enhancement After Intravenous Injection of Echogenic Immunoliposomes: Studies in a New Experimental Model , 2002, Circulation.
[93] Kejia Cai,et al. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin , 2006, Magnetic resonance in medicine.
[94] M. Doyle,et al. Chemical‐shift imaging: A hybrid approach , 1987, Magnetic resonance in medicine.
[95] S. Caruthers,et al. 1054-155 Antiangiogenic therapy of early atherosclerosis with paramagnetic ανβ3-integrin-targeted fumagillin nanoparticles , 2004 .
[96] Samuel A Wickline,et al. Targeted ultrasonic contrast agents for molecular imaging and therapy. , 2001, Current problems in cardiology.
[97] A. Becker,et al. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? , 1999, Cardiovascular research.
[98] Ying Yu,et al. c-Jun Decreases Voltage-Gated K+ Channel Activity in Pulmonary Artery Smooth Muscle Cells , 2001, Circulation.
[99] K. Peters,et al. Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina. , 1998, American heart journal.
[100] S. Caruthers,et al. Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery. , 2004, Current pharmaceutical biotechnology.
[101] M. Corjay,et al. alphavbeta3, alphavbeta5, and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formation. , 1999, Journal of cellular biochemistry.
[102] Samuel A Wickline,et al. Nanotechnology for molecular imaging and targeted therapy. , 2003, Circulation.
[103] Roger Y Tsien,et al. Imagining imaging's future. , 2003, Nature reviews. Molecular cell biology.
[104] Hisataka Kobayashi,et al. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. , 2003, Bioconjugate chemistry.
[105] F. Hennrich,et al. Spectroscopy of single- and double-wall carbon nanotubes in different environments. , 2005, Nano letters.
[106] René M. Botnar,et al. Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent. , 2005, American journal of respiratory and critical care medicine.
[107] M. Brechbiel,et al. Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores , 2001, Magnetic resonance in medicine.
[108] Zahi A Fayad,et al. Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. , 2004, Journal of the American Chemical Society.
[109] Kai Qi,et al. 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[110] Ralph Weissleder,et al. A fluorescent nanosensor for apoptotic cells. , 2006, Nano letters.
[111] Samuel A Wickline,et al. Molecular imaging, targeted therapeutics, and nanoscience , 2002, Journal of cellular biochemistry. Supplement.
[112] D. McPherson,et al. Intravascular ultrasound molecular imaging of atheroma components in vivo. , 2004, Journal of the American College of Cardiology.
[113] R. Virmani,et al. Sudden cardiac death. , 1987, Human pathology.
[114] C. Hoeller,et al. MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents. , 2004, Magnetic resonance imaging.